Esperion Therapeutics

Esperion Therapeutics, Inc.
Company typePublic
Nasdaq: ESPR
Russell 2000 Component
IndustryPharmaceutical
Founded2008; 16 years ago (2008)
Founder
  • Dr. Roger Newton
HeadquartersAnn Arbor, Michigan
Key people
Sheldon Koenig (president and CEO)
  • DecreaseUS$269.1 million (2020)
[1]
Total assets
  • IncreaseUS$381.6 million (2020)
[1]
WebsiteEsperion.com
Footnotes / references
financial information[2]: F-3, 4 

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

  1. ^ a b "2021 Annual Report Esperion". Retrieved 31 May 2022.
  2. ^ Cite error: The named reference 10k2013 was invoked but never defined (see the help page).